Reilly Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.66M | Buy |
28,020
+822
| +3% | +$40.7K | 0.12% | 108 |
|
|
2021
Q3 | $1.17M | Sell |
27,198
-4,442
| -14% | -$197K | 0.1% | 107 |
|
|
2021
Q2 | $1.24M | Buy |
31,640
+551
| +2% | +$21.4K | 0.1% | 106 |
|
|
2021
Q1 | $1.13M | Sell |
31,089
-147
| -0.5% | -$5.22K | 0.1% | 108 |
|
|
2020
Q4 | $1.15M | Buy |
31,236
+5,195
| +20% | +$191K | 0.11% | 105 |
|
|
2020
Q3 | $907K | Buy |
26,041
+217
| +0.8% | +$7.61K | 0.1% | 105 |
|
|
2020
Q2 | $801K | Sell |
25,824
-1,220
| -5% | -$41.4K | 0.09% | 106 |
|
|
2020
Q1 | $837K | Sell |
27,044
-12,991
| -32% | -$443K | 0.12% | 103 |
|
|
2019
Q4 | $1.49M | Buy |
40,035
+1,180
| +3% | +$42K | 0.17% | 91 |
|
|
2019
Q3 | $1.32M | Sell |
38,855
-268,743
| -87% | -$9.77M | 0.16% | 95 |
|
|
2019
Q2 | $12.6M | Buy |
307,598
+14,120
| +5% | +$561K | 1.58% | 17 |
|
|
2019
Q1 | $11.8M | Buy |
293,478
+6,723
| +2% | +$269K | 1.53% | 20 |
|
|
2018
Q4 | $11.9M | Sell |
286,755
-32,112
| -10% | -$1.33M | 1.73% | 12 |
|
|
2018
Q3 | $13.3M | Buy |
318,867
+3,989
| +1% | +$154K | 1.77% | 15 |
|
|
2018
Q2 | $10.8M | Sell |
314,878
-5,804
| -2% | -$198K | 1.54% | 23 |
|
|
2018
Q1 | $10.8M | Buy |
320,682
+8,566
| +3% | +$294K | 1.51% | 33 |
|
|
2017
Q4 | $10.7M | Sell |
312,116
-12,630
| -4% | -$431K | 1.52% | 27 |
|
|
2017
Q3 | $11M | Sell |
324,746
-3,008
| -0.9% | -$96.7K | 1.65% | 27 |
|
|
2017
Q2 | $10.4M | Buy |
327,754
+2,448
| +0.8% | +$77.2K | 1.6% | 30 |
|
|
2017
Q1 | $10.6M | Buy |
325,306
+6,644
| +2% | +$209K | 1.7% | 26 |
|
|
2016
Q4 | $9.82M | Sell |
318,662
-11,314
| -3% | -$345K | 1.7% | 23 |
|
|
2016
Q3 | $10.6M | Buy |
329,976
+12,554
| +4% | +$420K | 1.88% | 18 |
|
|
2016
Q2 | $10.6M | Buy |
+317,422
| New | +$10.1M | 1.95% | 14 |
|
|
2015
Q4 | – | Sell |
-35,979
| Closed | -$1.13M | – | 1338 |
|
|
2015
Q3 | $1.07M | Sell |
35,979
-12,709
| -26% | -$407K | 0.19% | 76 |
|
|
2015
Q2 | $1.55M | Sell |
48,688
-2,784
| -5% | -$90.7K | 0.27% | 59 |
|
|
2015
Q1 | $1.7M | Buy |
51,472
+1,501
| +3% | +$47.7K | 0.3% | 56 |
|
|
2014
Q4 | $1.48M | Sell |
49,971
-3,346
| -6% | -$95.9K | 0.35% | 47 |
|
|
2014
Q3 | $1.5M | Buy |
53,317
+16,789
| +46% | +$471K | 0.36% | 48 |
|
|
2014
Q2 | $1.04M | Buy |
36,528
+638
| +2% | +$18.2K | 0.25% | 54 |
|
|
2014
Q1 | $1.09M | Buy |
35,890
+5,530
| +18% | +$165K | 0.26% | 56 |
|
|
2013
Q4 | $882K | Buy |
30,360
+2,266
| +8% | +$65.9K | 0.22% | 58 |
|
|
2013
Q3 | $773K | Sell |
28,094
-2,116
| -7% | -$57.6K | 0.21% | 56 |
|
|
2013
Q2 | $794K | Buy |
+30,210
| New | +$835K | 0.24% | 56 |
|
Other funds holding PFE
Reilly Financial Advisors's PFE Position: Q4 2021 in Review
Reilly Financial Advisors increased its Pfizer (PFE) stake by 3% in Q4 2021, buying an estimated $40.7K and bringing the position to 28,020 shares worth $1.66M. The position accounts for 0.12% of the portfolio, ranked #108.
Reilly Financial Advisors first reported a position in PFE in Q2 2013 and has held it in 33 quarters since. The position peaked at $13.3M in Q3 2018. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2021.
- Reilly Financial Advisors held 28,020 shares of Pfizer worth $1.66M as of Q4 2021.
- Reilly Financial Advisors bought 822 Pfizer shares in Q4 2021, an estimated $40.7K.
- Pfizer made up 0.12% of Reilly Financial Advisors's portfolio in Q4 2021, its #108 holding.
- Reilly Financial Advisors first reported a position in Pfizer in Q2 2013 and has held it in 33 quarters since.
- Reilly Financial Advisors's Pfizer position peaked at $13.3M in Q3 2018.
- 3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.
Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.